Summary: Hearing loss has long been recognized as a leading modifiable risk factor for dementia, yet the real-world efficacy of hearing aids in preventing cognitive decline remains a subject of intense clinical debate. It has been historically unclear whether correcting sensory deprivation provides a universal shield against dementia or if its neuroprotective benefits are concentrated within highly vulnerable patient populations.
To resolve this ambiguity, researchers conducted a massive retrospective cohort study utilizing electronic health records from over 250 million patients within the global TriNetX network. The findings revealed a striking, highly localized brain-body connection: while hearing aid use showed no statistically significant association with reduced dementia risk in the general hearing-loss population, or among those with stroke, type 2 diabetes, heart failure, migraine, or osteoarthritis, it was associated with a dramatic 23% lower risk of dementia exclusively among adults living with both epilepsy and hearing loss.
Key Facts
- The Specificity Phenomenon: The 23% reduction in dementia risk was remarkably specific to the epilepsy cohort, showing a robust, highly reproducible correlation that was completely absent in other high-risk metabolic or cardiovascular groups.
- The 1-in-37 Prevention Threshold: Over a five-year monitoring period, correcting hearing loss in epilepsy patients yielded an absolute risk reduction of 2.7%, translating clinically to preventing one full case of dementia for every 37 patients fitted with hearing aids.
- The Cognitive Reserve Exhaustion Model: Investigators hypothesize that while standard individuals possess enough baseline “cognitive reserve” to absorb the extra neural strain of processing muffled sounds, epilepsy patients have depleted cognitive reserves, making the addition of sensory deprivation a tipping point into dementia.
- Temporal Lobe Vulnerability: Temporal lobe epilepsy directly degrades the identical cortical regions responsible for central auditory processing, compounding the cellular damage caused by peripheral hearing loss.
- Anticonvulsant Side-Effects: The study notes that certain anti-seizure medications (ASMs) can actively worsen or accelerate hearing impairment, building a dangerous, hidden loop between epilepsy treatment and sensory degradation.
- A Call for Routine Screenings: Because epilepsy patients are already closely embedded in regular neurology and clinical pipelines, the research team advocates for the immediate, universal integration of simple, non-invasive hearing screenings into routine epilepsy care.
Source: European Academy of Neurology
Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
Hearing loss is widely recognised as the largest modifiable risk factor for dementia. Yet whether hearing aids can reduce dementia risk remains debated. In particular, it is unclear whether any benefit may be greater in people with neurological, metabolic or cardiovascular conditions that place them at increased risk of developing dementia.
To explore this, researchers from University Hospital Zurich and the University of Liverpool analysed electronic health records from more than 250 million patients in the TriNetX network.
They compared adults with hearing loss who used hearing aids with closely matched adults who did not. The analysis included the overall hearing-loss population as well as people living with epilepsy, stroke, type 2 diabetes, chronic kidney disease, heart failure, migraine and osteoarthritis.
No significant association was found between hearing aid use and dementia risk in the overall population with hearing loss, nor among people with stroke, migraine, type 2 diabetes, chronic kidney disease, heart failure or osteoarthritis.
However, among adults with both epilepsy and hearing loss, hearing aid use was associated with a 23% lower risk of dementia. This corresponded to an absolute risk reduction of 2.7 percentage points over five years, equivalent to one fewer case of dementia for every 37 people using hearing aids. The association remained directionally consistent across all analyses.
Commenting on the findings, lead author Dr Carolina Ferreira-Atuesta said: “What surprised us most was how specific the finding was to epilepsy. We expected to see a small benefit across several of the higher-risk groups we studied. Instead, most showed no significant association, while the association in epilepsy was observed consistently across all of our analyses. That consistency gives us greater confidence that this is a meaningful finding.”
The researchers believe the findings may be explained by differences in cognitive reserve – the brain’s ability to continue functioning effectively despite age-related changes or damage caused by disease.3
Dr Ferreira-Atuesta explained: “Most people with hearing loss have enough cognitive reserve to absorb the extra effort caused by hearing impairment, so correcting it may not have a large effect on dementia risk. Epilepsy is different because cognitive reserve is often already reduced, meaning that removing one additional source of strain may have a greater impact.”
“There are several biologically plausible reasons why we might see this effect in epilepsy. The condition is associated with accelerated cognitive decline, temporal lobe epilepsy affects areas of the brain involved in hearing and some anti-seizure medications may worsen hearing,” added Dr Ferreira-Atuesta.
The findings have important implications for clinical practice, according to the researchers. Since people with epilepsy are already in regular contact with healthcare services, hearing assessments could be readily incorporated into routine care.
“Hearing loss is one of the few dementia risk factors we can actually do something about,” said Dr Ferreira-Atuesta. “It’s easy to detect, and hearing aids are established, reversible and low-risk. This is a real call for increased awareness and screening. We have a vulnerable population, a problem that’s straightforward to identify and a correction that’s simple to deliver.”
For people living with epilepsy and hearing loss, the researchers emphasise that the benefits of addressing hearing loss extend beyond any potential effect on dementia risk. “If you have hearing loss, treat it,” Dr Ferreira-Atuesta urged. “The benefits for communication, mood and staying connected are real and well established, so there’s every reason to act now.”
The researchers caution that the study was observational and cannot yet prove that hearing aids directly reduce dementia risk. However, the findings are encouraging and biologically plausible. Further prospective studies are needed to determine whether hearing aids can help protect long-term brain health in people with epilepsy and hearing loss.
Key Questions Answered:
A: The answer comes down to a concept called “cognitive reserve”, the brain’s built-in cushion that allows it to continue thinking clearly despite age-related changes or disease damage. When an otherwise healthy person develops hearing loss, their brain has to work much harder to decode muffled sounds, but they usually have enough reserve power to absorb that extra mental strain. In patients with epilepsy, however, this cognitive cushion is often already heavily depleted due to ongoing seizure activity and tissue loss. Removing the massive, exhausting daily strain of struggling to hear relieves just enough pressure from an already overloaded brain to keep them from crossing the threshold into functional dementia.
A: Epilepsy and hearing loss share a highly dangerous anatomical overlapping zone. The temporal lobes are the primary structures responsible for managing memory, language, and central auditory processing, it is where your brain makes sense of sound. Crucially, the temporal lobes are also the most common source of focal seizures in adult epilepsy. When temporal lobe epilepsy repeatedly shocks these networks, it damages the exact same brain regions that are already starving for clear sensory information due to ear impairment. Furthermore, some anti-seizure medications can cause ototoxicity (chemical damage to the inner ear), creating a destructive loop where treating the seizures accidentally accelerates hearing loss and cortical strain.
A: The immediate takeaway is that hearing tracking needs to become a standard pillar of epilepsy care. Hearing loss is one of the very few dementia risk factors that we can easily detect and safely reverse with low-risk, established tools like hearing aids. Since epilepsy patients are already in regular contact with neurologists, adding routine hearing screenings to their checkups is incredibly straightforward. Beyond any potential protection against dementia, treating hearing loss instantly enhances mood, halts social isolation, and improves day-to-day communication, giving patients and families every reason to take immediate action.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this dementia and auditory neuroscience research news
Author:Â Luke Paskins
Source:Â European Academy of Neurology
Contact: Luke Paskins – European Academy of Neurology
Image:Â The image is credited to Neuroscience News
Original Research:Â The findings will be presented at the 12th Congress of the European Academy of Neurology
